Several clinical studies have found that cannabinoids or marijuana reduce intraocular pressure (IOP) as well as do most conventional glaucoma medications. This is true whether the cannabinoids are administered orally, intravenously, or by inhalation but not when they are applied directly to the eye.
Glaucoma ranks among the most frequently cited reasons for using medical marijuana and is one of the indications for which the federal government once granted permission for compassionate marijuana use Research findings from as early as the 1970s show that both marijuana and THC reduce intraocular pressure, a key contributor to glaucoma.
Glaucoma ranks among the most frequently cited reasons for using medical marijuana and is one of the indications for which the federal government once granted permission for compassionate marijuana.
It’s worth noting, however, that the benefits of marijuana for glaucoma patients are typically short-lived and may require frequent dosing. Additionally, marijuana use may have unwanted side effects, including impaired coordination and cognitive function, dry mouth, and red eyes. As a result, it is important for glaucoma patients to discuss the potential benefits and risks of marijuana use with their healthcare provider.
Keywords: Cannabis; epilepsy; sizures; marihuana; marijuana